PlainRecalls
FDA Drug Low Class III Terminated

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540

Reported: November 21, 2018 Initiated: November 2, 2018 #D-0257-2019

Product Description

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540

Reason for Recall

Cross Contamination with Other Products

Details

Recalling Firm
Sandoz Inc
Units Affected
14366 bottles
Distribution
Nationwide within the United States
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540. Recalled by Sandoz Inc. Units affected: 14366 bottles.
Why was this product recalled?
Cross Contamination with Other Products
Which agency issued this recall?
This recall was issued by the FDA Drug on November 21, 2018. Severity: Low. Recall number: D-0257-2019.